|NCTC Number:||NCTC 14295|
|Current Name:||Yersinia enterocolitica|
|Hazard Group (ACDP):||2|
|Release Restrictions:||Terms & Conditions of Supply of Microbial Pathogens: Safety|
|Antigenic Properties:||O Unidentifiable|
|Conditions for growth on solid media:||Columbia Blood agar, 30C, O2, 48 hours|
|Isolated From:||Human (inpatient), bronchial wash. Liverpool, UK. 24.05.2017.|
|Bibliography:||Inns T. et al. First use of whole-genome sequencing to investigate a cluster of Yersinia enterocolitica, Liverpool, United Kingdom, 2017. J Med Microbiol. 2018 Dec;67(12):1747-1752.|
|Other Typing Information:||Sequence type 309; Biotype 1a|
|History:||Accessioned into NCTC < M. Wright < Isolated by the Royal Liverpool and Broadgreen Hospital Microbiology Department (Liverpool, UK)|
|Authority:||(Schleifstein and Coleman 1939) Frederiksen 1964|
|Depositor:||M. Wright (Gastrointestinal Bacteria Reference Unit, Public Health England, Colindale, London, UK)|
|Biosafety Responsibility:||It is the responsibility of the customer to ensure that their facilities comply with bio-safety regulations for their own country.|
The Culture Collections hold cell cultures, bacteria, fungi and virus strains from worldwide sources. Our scientists ensure that the identification of the cultures is correct and they remain unchanged from when they are first deposited with the Collection. Nevertheless, some of the data we provide about the cultures is supplied by the person depositing the strains and, although we have multiple checking procedures in place, we cannot always verify all their data. Please note that the Culture Collections cannot be held responsible for any inaccuracies in the data provided by the depositors.
Cultures supplied by Culture Collections are to be used as controls for microbiology testing and for research purposes only. Please view the Terms & Conditions of Supply for more information.
Contact us if you want to discuss commercial use of the cultures.
Please confirm your country of origin from the list below.